Transactions
May 8, 2001
Mintz Levin: Pharmaceutical Company to Buy Aurora Biosciences
Boston's Vertex Pharmaceuticals Inc. has agreed to acquire San Diego's Aurora Biosciences Corp. for $592 million in stock. Vertex Pharmaceuticals uses biophysics, chemistry and computer-based modeling, rather than the traditional trial-and-error approach, to develop drugs.
Vertex Pharmaceuticals uses biophysics, chemistry and computer-based modeling, rather than the traditional trial-and-error approach, to develop drugs.
Aurora Biosciences develops and sells drug-discovery...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In